Evidence map›Paper›PMID 34696495›Full record

ArticleViruses2021

High-Throughput Next-Generation Sequencing Respiratory Viral Panel: A Diagnostic and Epidemiologic Tool for SARS-CoV-2 and Other Viruses.

Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Zachary Petty, Jiani Chen, Sudha Ananth, Pankaj Ahluwalia, Colin Williams, Ted M Ross, Alka Chaubey and 4 more

Abstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Detection of zoonotic pathogens in invasive black rats (Frontiers in veterinary science · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nikhil S SahajpalDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Ashis K MondalDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0003-3826-9489
Allan NjauDepartment of Pathology, Aga Khan University Hospital, Nairobi 30270-00100, Kenya.ORCID 0000-0002-3566-0629
Zachary PettyCenter for Ecology of Infectious Diseases, Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.
Jiani ChenCenter for Ecology of Infectious Diseases, Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.
Sudha AnanthDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Pankaj AhluwaliaDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Colin WilliamsDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Ted M RossCenter for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0003-1947-7469
Alka ChaubeyDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-0914-9237
Grace DeSantisResearch and Development, Illumina Inc., San Diego, CA 92122, USA.
Gary P SchrothResearch and Development, Illumina Inc., San Diego, CA 92122, USA.ORCID 0000-0002-3055-056X
Justin BahlCenter for Ecology of Infectious Diseases, Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0001-7572-4300
Ravindra KolheDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-8283-2403

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
CDC HHS 75D30121C10133NIAID NIH HHS 75N93019C00052NIH CEIRS contracts HHSN272201400006C and HHSN27220140000
6 · The paper itself

Abstract

Two serious public health challenges have emerged in the current COVID-19 pandemic namely, deficits in SARS-CoV-2 variant monitoring and neglect of other co-circulating respiratory viruses. Additionally, accurate assessment of the evolution, extent, and dynamics of the outbreak is required to understand the transmission of the virus. To address these challenges, we evaluated 533 samples using a high-throughput next-generation sequencing (NGS) respiratory viral panel (RVP) that includes 40 viral pathogens. The performance metrics revealed a PPA, NPA, and accuracy of 95.98%, 85.96%, and 94.4%, respectively. The clade for pangolin lineage B that contains certain distant variants, including P4715L in ORF1ab, Q57H in ORF3a, and S84L in ORF8 covarying with the D614G spike protein mutation, were the most prevalent early in the pandemic in Georgia, USA. The isolates from the same county formed paraphyletic groups, indicating virus transmission between counties. The study demonstrates the clinical and public health utility of the NGS-RVP to identify novel variants that can provide actionable information to prevent or mitigate emerging viral threats and models that provide insights into viral transmission patterns and predict transmission/resurgence of regional outbreaks as well as providing critical information on co-circulating respiratory viruses that might be independent factors contributing to the global disease burden.

Indexed as

COVID-19Genome, ViralHigh-Throughput Nucleotide SequencingHumansLimit of DetectionPhylogenyRespiratory Tract InfectionsSARS-CoV-2Spike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike glycoprotein, SARS-CoVco-circulating virusCOVID-19diagnosisepidemiologyGeorgiarespiratory viral panelSARS-CoV-2

Identifiers

PMID34696495
PMCPMC8540770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.